VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹112 Cr | ₹80 Cr | ₹77 Cr | ₹39 Cr | ₹32 Cr |
What is the latest Sundry Debtors ratio of VENUS REMEDIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹112 Cr |
| Mar2024 | ₹80 Cr |
| Mar2023 | ₹77 Cr |
| Mar2022 | ₹39 Cr |
| Mar2021 | ₹32 Cr |
How is Sundry Debtors of VENUS REMEDIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹112 Cr | 39.40 | |
| Mar2024 | ₹80 Cr | 5.01 | |
| Mar2023 | ₹77 Cr | 98.60 | |
| Mar2022 | ₹39 Cr | 20.47 | |
| Mar2021 | ₹32 Cr | - | |
Compare Sundry Debtors of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,413.7 Cr | 6.8% | 95.1% | 302.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 6.8% |
95.1% |
302.6% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses